Javelo Health Limited

Javelo Health Limited manufactures advanced infusion line securement devices designed to prevent peripheral intravenous catheter (PIVC) complications. The company's proprietary elastomeric securement solution addresses a critical clinical gap: up to 50% of infusion patients experience line displacement and associated complications, leading to patient harm, care delays, and increased costs. Javelo's device features skin-soft material, broad tubing compatibility (2.2–10 mm OD), single-patient reusability with wipe-clean capability (up to 15 uses), and is available in adult and pediatric sizes from 1 year of age. The product integrates seamlessly into clinical workflows across acute and outpatient settings, with >90% patient and healthcare provider preference demonstrated in clinical evaluations. Backed by Imperial College London research and regulatory approvals (UKCA), Javelo serves leading public and private healthcare providers in the UK, US, and internationally.